DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study (Propel)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Rigshospitalet, Denmark
Herlev Hospital
Odense University Hospital
Vejle Hospital
Aalborg Universityhospital
Danish Center for Interventional Research in Radiation Oncology (CIRRO)
Information provided by (Responsible Party):
University of Aarhus
ClinicalTrials.gov Identifier:
NCT01417676
First received: August 15, 2011
Last updated: November 22, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2021
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)